Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Europa Donna and breast screening

Published: 31 Mar 2009

Views: 14224

Rating:

Save

Dr Giovanna Gatti - Breast Surgeon and President of the Italian Branch of Europa Donna

Dr Giovanna Gatti, Breast Surgeon at the European Institute of Oncology, Milan, and President of the Italian Branch of Europa Donna, discusses her work combinig both fields and the 'Zero Mortality' project started by Professor Umberto Veronesi.

Related Videos

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Genomic testing: Awareness and effective communication between healthcare professionals and patients

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy

Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy ( Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA )

Community-based breast cancer control programme in the Philipines

Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines

Community-based breast cancer control programme in the Philipines ( Kara Magsanoc-Alikpala - ICanServe Foundation, Manila, Philippines )

Initiatives for cancer control in Indonesia

Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta, Indonesia

Initiatives for cancer control in Indonesia ( Dr K Kardinah - National Cancer Center/Dharmais Cancer Hospital, Jakarta, Indonesia )

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain

PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )

Precision oncology: Present and future in breast cancer

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Precision oncology: Present and future in breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Advancing breast cancer diagnosis in the developing world

Dr Hans Junkermann, Prof Dr Erkin Arıbal and Dr Richard Rainsbury

Advancing breast cancer diagnosis in the developing world ( Dr Hans Junkermann, Prof Dr Erkin Arıbal and Dr Richard Rainsbury )

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )

More from ecancer